Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Director's Dealing 2011

Feb 28, 2011

34595_dirs_2011-02-28_0546e49d-bbb5-46fb-91f0-0859480b3aa5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2011-02-24

Reporting Person: Chilton Anthony S (Director, CEO and President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-02-24 Option to purchase common shares $2.25 A 25000 Acquired 2021-02-24 Common Shares (25000) Direct

Footnotes

F1: The option was granted pursuant to Dr. Chilton's employment agreement and vests and becomes exercisable in two equal installments of 12,500 shares each on January 31, 2012 and January 31, 2013.